Recent News

• 10.30.2025 - Q3 2025 Earnings Call
• 10.30.2025 - Q3 2025 Earnings Call
• 08.07.2025 - Q2 2025 Earnings Call
• 08.07.2025 - Q2 2025 Earnings Call
• 05.01.2025 - Q1 2025 Earnings Call
• 05.01.2025 - Q1 2025 Earnings Call
• 04.17.2025 - Lilly confirms date and conference call for first-quarter 2025 financial results announcement
• 04.17.2025 - Lilly confirms date and conference call for first-quarter 2025 financial results announcement
• 04.17.2025 - Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
• 04.17.2025 - Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial

Recent Filings

• 04.16.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.31.2025 - PX14A6G Notice of exempt solicitation submitted by non-management